HSCS — HeartSciences Share News
0.000.00%
Last trade - 00:00- $15.26m
- $18.96m
- $0.00m
Brief: Heartsciences Announces Further Internationalization Of Its Patent Portfolio
Brief: Heart Test Laboratories Inc Entered Into Amendment No. 4 To The Loan And Security Agreement
Brief: Heart Test Laboratories Receives Letter From Nasdaq Indicating Co Is Not In Compliance With Nasdaq Listing Rule
Brief: HeartSciences Provides Business Update, Reports Q2 Financial Results
Brief: Heartsciences' Myovista Technology Used To Develop Ai-ECG Algorithm To Identify Patients At Risk Of Adverse Cardiovascular Events
Brief: Heart Test Laboratories Inc granted European patent for proprietary electrode and cable connections for use with AI based Myovista ECG
U.S. STOCKS ON THE MOVE-Starbucks, Tesla, Wynn Resorts
Brief: Heartsciences Announces The Issuance Of Cpt Codes By The American Medical Association For ECG Ai Analysis Of Cardiac Dysfunction
Brief: HeartSciences Granted U.S. Patent For ECG Assessment Of Heart Diastolic Function
Brief: Heart Test Laboratories Inc Says On Track For MyoVista FDA De Novo Resubmission In Current Fiscal Year
Brief: Heart Test Laboratories Inc Says Myovista Fda De Novo Resubmission Expected In Current Fiscal Year